{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:40:05Z","timestamp":1771339205948,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPPGH5295"],"award-info":[{"award-number":["OPPGH5295"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide. In Afghanistan, where most births take place at home without the assistance of a skilled birth attendant, there is a need for options to manage PPH in community-based settings. Misoprostol, a uterotonic that has been used as prophylaxis at the household level and has also been proven to be effective in treating PPH in hospital settings, is one possible option.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A double-blind, randomized placebo-controlled trial was conducted in six districts in Badakhshan Province, Afghanistan to test the effectiveness and safety of administering 800mcg sublingual misoprostol to women after a home birth for treatment of excessive blood loss. Consenting women were enrolled prior to delivery and given 600mcg misoprostol to self-administer orally as prophylaxis. Community health workers (CHW) were trained to observe for signs of PPH after delivery and if PPH was diagnosed, administer the study medication (misoprostol or placebo) and immediately refer the woman. A hemoglobin (Hb) decline of 2\u2009g\/dL or greater, measured pre- and post-delivery, served as the primary outcome; side effects, additional interventions, and transfer rates were also analyzed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Among the 1884 women who delivered at home, nearly all (98.7%) reported self-use of misoprostol for PPH prevention. A small fraction was diagnosed with PPH (4.4%, 82\/1884) and was administered treatment. Hb outcomes, including the proportion of women with a Hb drop of 2\u2009g\/dL or greater, were similar between the study groups (misoprostol: 56.4% (22\/39), placebo: 60.6% (20\/33), <jats:italic>p<\/jats:italic>\u2009=\u20090.45). Significantly more women randomized to receive misoprostol experienced shivering (82.5% vs. placebo: 61.5%, <jats:italic>p<\/jats:italic>\u2009=\u20090.03). Other side effects were similar between study groups and none required treatment, including among the subset of 39 women, who received misoprostol for both of its PPH indications.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>While the study did not document a clinical benefit associated with misoprostol for treatment of PPH, study findings suggest that use of misoprostol for both prevention and treatment in the same birth as well as its use by lay level providers in home births does not result in any safety concerns.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>This trial was registered with <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>, number <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01508429\">NCT01508429<\/jats:ext-link> Registered on December 1, 2011.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12978-020-00933-8","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T15:03:44Z","timestamp":1591369424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Testing a home-based model of care using misoprostol for prevention and treatment of postpartum hemorrhage: results from a randomized placebo-controlled trial conducted in Badakhshan province, Afghanistan"],"prefix":"10.1186","volume":"17","author":[{"given":"Dina F.","family":"Abbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafiq","family":"Mirzazada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5572-8133","authenticated-orcid":false,"given":"Jill","family":"Durocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahfaqir","family":"Pamiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meagan E.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"933_CR1","first-page":"CD000494","volume":"8","author":"\u00d6 Tun\u00e7alp","year":"2012","unstructured":"Tun\u00e7alp \u00d6, Hofmeyr GJ, G\u00fclmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012;8:CD000494.","journal-title":"Cochrane Database Syst Rev"},{"key":"933_CR2","first-page":"CD003249","volume":"2","author":"HA Mousa","year":"2014","unstructured":"Mousa HA, Blum J, Abou E, Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev. 2014;2:CD003249.","journal-title":"Cochrane Database Syst Rev"},{"key":"933_CR3","first-page":"CD011689","volume":"4","author":"ID Gallos","year":"2018","unstructured":"Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tun\u00e7alp \u00d6, G\u00fclmezoglu A, Hofmeyr G, Coomarasamy A. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;4:CD011689.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"933_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ijgo.12181","volume":"138","author":"JL Morris","year":"2017","unstructured":"Morris JL, Winikoff B, Dabash R, Weeks A, Faundes A, Gemzell-Danielsson K, Kapp N, Castleman L, Kim C, Ho PC, Visser GHA. FIGO\u2019s updated recommendations for misoprostol used alone in gynecology and obstetrics. Int J Gynaecol Obstet. 2017;138(3):363\u20136.","journal-title":"Int J Gynaecol Obstet"},{"key":"933_CR5","volume-title":"WHO recommendations for the prevention and treatment of postpartum haemorrhage","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization; 2012."},{"issue":"3","key":"933_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.9745\/GHSP-D-14-00034","volume":"2","author":"JM Smith","year":"2014","unstructured":"Smith JM, Currie S, Cannon T, Armbruster D, Perri J. Are national policies and programs for prevention and management of postpartum hemorrhage and preeclampsia adequate? A key information survey in 37 countries. Glob Health Sci Pract. 2014;2(3):275\u201384.","journal-title":"Glob Health Sci Pract"},{"issue":"3","key":"933_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/1471-0528.12049","volume":"120","author":"V Hundley","year":"2012","unstructured":"Hundley V, Avan B, Sullivan C, Graham W. Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence. BJOG. 2012;120(3):277\u201387.","journal-title":"BJOG"},{"key":"933_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/IJWH.S89315","volume":"8","author":"N Prata","year":"2016","unstructured":"Prata N, Weidert K. Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning. Int J Women's Health. 2016;8:341\u20139.","journal-title":"Int J Women's Health"},{"issue":"1","key":"933_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijgo.2005.03.007","volume":"90","author":"N Prata","year":"2005","unstructured":"Prata N, Mbaruku G, Campbell M, Potts M, Vahidnia F. Controlling postpartum hemorrhage after home births in Tanzania. Int J Gynaecol Obstet. 2005;90(1):51\u20135.","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"933_CR10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/17441692.2017.1303743","volume":"13","author":"K Hobday","year":"2018","unstructured":"Hobday K, Hulme J, Belton S, Homer CS, Prata N. Community-based misoprostol for the prevention of post-partum haemorrhage: a narrative review of the evidence base, challenges and scale-up. Glob Public Health. 2018;13(8):1081\u201397.","journal-title":"Glob Public Health"},{"key":"933_CR11","unstructured":"Afghan Public Health Institute, Ministry of Public Health (APHI\/MoPH) [Afghanistan], Central Statistics Organization (CSO) [Afghanistan], ICF Macro, Indian Institute of Health Management Research (IIHMR) [India], and World Health Organization Regional Office for the Eastern Mediterranean (WHO\/EMRO) [Egypt]. Afghanistan Mortality Survey 2010. Calverton: APHI\/MoPH, CSO, ICF Macro, IIHMR and WHO\/EMRO. p. 2011."},{"issue":"3","key":"933_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ijgo.2009.12.003","volume":"108","author":"H Sanghvi","year":"2010","unstructured":"Sanghvi H, Ansari N, Prata NJ, Gibson H, Ehsan AT, Smith JM. Prevention of postpartum hemorrhage at home birth in Afghanistan. Int J Gynaecol Obstet. 2010;108(3):276\u201381.","journal-title":"Int J Gynaecol Obstet"},{"key":"933_CR13","doi-asserted-by":"publisher","unstructured":"Najafizada SA, Labont\u00e9 R, Bourgeault IL. Community health workers of Afghanistan: a qualitative study of a national program. Confl Heal. 2014. https:\/\/doi.org\/10.1186\/1752-1505-8-26.","DOI":"10.1186\/1752-1505-8-26"},{"key":"933_CR14","unstructured":"Ministry of Public Health, Islamic Republic of Afghanistan. National Reproductive, Maternal, Newborn, Child and Adolescent Health (RMNCAH) Strategy, 2017\u20132021. Kabul; 2017."},{"issue":"9710","key":"933_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(09)61923-1","volume":"375","author":"J Blum","year":"2010","unstructured":"Blum J, Winikoff B, Raghavan S, Dabash R, Ramadan MC, Dilbaz B, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Lancet. 2010;375(9710):217\u201323.","journal-title":"Lancet"},{"issue":"9710","key":"933_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0140-6736(09)61924-3","volume":"375","author":"B Winikoff","year":"2010","unstructured":"Winikoff B, Dabash R, Durocher J, Darwish E, Nguyen TN, Leon W, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet. 2010;375(9710):210\u20136.","journal-title":"Lancet"},{"issue":"3","key":"933_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ijgo.12756","volume":"144","author":"DF Abbas","year":"2019","unstructured":"Abbas DF, Jehan N, Diop A, Durocher J, Byrne ME, Zuberi N, Ahmed Z, Walraven G, Winikoff B. Using misoprostol to treat postpartum hemorrhage in home deliveries attended by traditional birth attendants. Int J Gynaecol Obstet. 2019;144(3):290\u20136.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"933_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/1471-0528.13540","volume":"123","author":"S Raghavan","year":"2016","unstructured":"Raghavan S, Geller S, Miller S, Goudar SS, Anger H, Yadavannavar MC, Dabash R, Bidri SR, Gudadinni MR, Udgiri R, Koch AR, Bellad MB, Winikoff B. Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster randomised non inferiority community trial. BJOG. 2016;123(1):120\u20137.","journal-title":"BJOG"},{"issue":"2","key":"933_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087683","volume":"9","author":"A Byrne","year":"2014","unstructured":"Byrne A, Hodge A, Jimenez-Soto E, Morgan A. What works? Strategies to increase reproductive, maternal and child health in difficult to access mountainous locations: a systematic literature review. PLoS One. 2014;9(2):e87683.","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"933_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/jp.2016.33","volume":"36","author":"S Gogia","year":"2016","unstructured":"Gogia S, Sachdev HP. Home-based neonatal care by community health workers for preventing mortality in neonates in low- and middle-income countries: a systematic review. J Perinatol. 2016;36(Suppl 1):55\u201373.","journal-title":"J Perinatol"},{"issue":"1","key":"933_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/heapol\/czv012","volume":"31","author":"HJ Smith","year":"2016","unstructured":"Smith HJ, Colvin CJ, Richards E, Roberson J, Sharma G, Thapa K, G\u00fclmezoglu AM. Programmes for advance distribution of misoprostol to prevent post-partum haemorrhage: a rapid literature review of factors affecting implementation. Health Policy Plan. 2016;31(1):102\u201313.","journal-title":"Health Policy Plan"},{"issue":"8","key":"933_CR22","doi-asserted-by":"publisher","first-page":"e70446","DOI":"10.1371\/journal.pone.0070446","volume":"8","author":"A El Ayadi","year":"2013","unstructured":"El Ayadi A, Raifman S, Jega F, Butrick E, Ojo Y, Geller S, Miller S. Comorbidities and lack of blood transfusion may negatively affect maternal outcomes of women with obstetric hemorrhage treated with NASG. PLoS One. 2013;8(8):e70446.","journal-title":"PLoS One"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-020-00933-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12978-020-00933-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-020-00933-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T23:16:10Z","timestamp":1622848570000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/s12978-020-00933-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1186\/s12978-020-00933-8","relation":{},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"28 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol was approved from the Afghanistan Ministry of Public Health, Afghanistan Public Health Institute Institutional Review Board. Informed consent was received from all participants before enrollment in the study or any data collection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no financial or non-financial competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}